v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net Loss $ (953,185) $ (1,086,597)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation 4,195 11,203
Amortization 35,635 35,634
Amortization of debt discount 25,000
Stock issued for services 750 24,024
Changes in operating assets and liabilities    
Decrease in accounts receivable 9,553 217
Increase in inventory (7,225) (246)
Increase in other current assets (2,444) (5,340)
Increase in accounts payable and accrued expenses 771,801 414,359
Net cash used in operating activities (115,920) (606,746)
Net cash used in investing activities
Cash flows from financing activities:    
Proceeds from sale of common stock 50,000 283,000
Proceeds from issuance of notes payable, related parties 20,000
Proceeds from issuance of convertible notes payable, related parties 70,000
Proceeds from sale of interest in variable interest entity 260,000
Payments made on notes payable (7,500)
Net cash provided by financing activities 140,000 535,500
Net increase (decrease) increase in cash and cash equivalents 24,080 (71,246)
Cash and cash equivalents, beginning of period 3,179 108,035
Cash and cash equivalents, end of period 27,259 36,789
Supplemental cash flow information:    
Interest paid
Cash paid for income taxes
Schedule of Non-Cash Investing and Financing Activities:    
Issuance of notes payable for accrued directors fees 38,000
Issuance of notes payable for accrued base salary 115,542
Issuance of notes payable for accounts payable, related parties 137,500
Issuance of common stock as consideration for accounts payable $ 29,000